Skip to main content
profile image
Selected Works of Katherine R. Tuttle, MD, FASN, FACP, FNKF
Article
233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7
Diabetes (2019)
  • Katherine R. Tuttle, Spokane, WA, Cape Town, South Africa, Indianapolis, IN
  • Brian L. Rayner, Spokane, WA, Cape Town, South Africa, Indianapolis, IN
  • Mark Lakshmanan, Spokane, WA, Cape Town, South Africa, Indianapolis, IN
  • Brad Woodward, Spokane, WA, Cape Town, South Africa, Indianapolis, IN
  • Anita Kwan, Spokane, WA, Cape Town, South Africa, Indianapolis, IN
  • Manige Konig, Spokane, WA, Cape Town, South Africa, Indianapolis, IN
  • Fady T. Botros, Spokane, WA, Cape Town, South Africa, Indianapolis, IN
Link
Disciplines
Publication Date
June 1, 2019
DOI
10.2337/db19-233-or
Citation Information
Katherine R. Tuttle, Brian L. Rayner, Mark Lakshmanan, Brad Woodward, et al.. "233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7" Diabetes Vol. 68 (2019)
Available at: http://works.bepress.com/katherine-tuttle/223/